Mr. Elad Bibi-Aviv reports

SEEGNAL INC. ANNOUNCES EXTENSION OF ITS NON-BROKERED PRIVATE PLACEMENT

Seegnal Inc. has extended its previously announced non-brokered private placement on June 2, 2026, of up to 4,642,857 units in the capital of the company, for gross proceeds of up to $1.3-million, at a price of 28 cents per unit. Each unit comprises one common share in the capital of the company and one common share purchase warrant. Each warrant is exercisable to acquire one common share at a price of 50 cents for a period of 36 months.

The company has received an extension from the TSX Venture Exchange for the offering. The company expects that the offering will close on or before Aug. 31, 2026, in one or more tranches. For further details on the offering, see the company's news release dated June 2, 2026.

About Seegnal Inc.

Seegnal is an innovative healthcare technology company dedicated to reducing medication-related harm where care begins. The company's software-as-a-service-based clinical decision support platform is designed to help clinicians prescribe with greater precision by integrating patient-specific data at the point of care, including medications, laboratory results, renal function, allergies, age and other relevant risk factors. By delivering more targeted, context-aware medication alerts within existing clinical workflows, Seegnal aims to reduce alert fatigue, support safer prescribing and advance a more personalized standard of patient care. Seegnal's technology is deployed across health care settings and is used by more than 15,000 clinicians in daily practice.

We seek Safe Harbor.